Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 10 Glioblastoma 9 Fallopian Tube Neoplasms 8 Colorectal Neoplasms 8 Breast Neoplasms 8 Lung Neoplasms 7 Rectal Neoplasms 6 Neoplasm Metastasis 6 Gliosarcoma 6 Colonic Neoplasms 6 Carcinoma, Renal Cell 6 Brain Neoplasms 6 Prostatic Neoplasms 4 Melanoma 4 Uterine Cervical Neoplasms 3 Solitary Fibrous Tumor, Pleural 3 Sarcoma, Alveolar Soft Part 3 Sarcoma 3 Mesothelioma, Malignant 3 Carcinoma, Hepatocellular 3 Breast Neoplasms, Male 3 Advanced Solid Tumor 3 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Leukemia, Myeloid, Acute 2

Interventions

cediranib 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Prostate Adenocarcinoma × cediranib × Clear all

NCT00502164 2011-01-21

AZD2171IL/0003

AstraZeneca

Phase 1 Completed

Advanced Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡